MedPath

The effectiveness of Vonoprazan for ulcer healing and prevention of delayed bleeding after gastric ESD: a prospective observational study.

Not Applicable
Conditions
Gastric tumor
Registration Number
JPRN-UMIN000022269
Lead Sponsor
Kyoto Prefectural University of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
250
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Patients with active peptic ulcer (2)Patients with the history of gastrectomy (3)The lesion which are recurrence of endoscopic resection before (4)Patients with intake of mucosal protective agent or antacid (5)Patients with severe anemia (6)Patients with severe liver dysfunction (7)Patients with severe renal dysfunction (8)Patients with allergy for Vonoprazan (9)Patients without written informed consent (10)Patients with the possibility of the pregnancy or the pregnancy and lactating (11)Ineligible patients certified by doctors

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath